Drug & Gene Delivery Devices Market by Route of Administration (Inhalation, Injectable, Nasal), Method (Ex vivo, In situ), Vector - Global Forecast 2024-2030

Drug & Gene Delivery Devices Market by Route of Administration (Inhalation, Injectable, Nasal), Method (Ex vivo, In situ), Vector - Global Forecast 2024-2030


The Drug & Gene Delivery Devices Market size was estimated at USD 4.33 billion in 2023 and expected to reach USD 4.79 billion in 2024, at a CAGR 10.72% to reach USD 8.83 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Drug & Gene Delivery Devices Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Drug & Gene Delivery Devices Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Drug & Gene Delivery Devices Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Antares Pharma, Inc., B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Eisai Co., Ltd., Enable Injections, Inc., Gerresheimer AG, Insulet Corporation, Johnson & Johnson Services Inc., Koninklijke Philips N.V., Merck KGaA, OraSure Technologies, Inc., Oxford BioMedica PLC, and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Drug & Gene Delivery Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

Route of Administration
Inhalation

Injectable

Nasal

Ocular

Oral

Topical

Transdermal
Method
Ex vivo

In situ
Vector
Non-viral

Viral
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas

Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam

Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Drug & Gene Delivery Devices Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Drug & Gene Delivery Devices Market?
3. What are the technology trends and regulatory frameworks in the Drug & Gene Delivery Devices Market?
4. What is the market share of the leading vendors in the Drug & Gene Delivery Devices Market?
5. Which modes and strategic moves are suitable for entering the Drug & Gene Delivery Devices Market?PDF E-mail From Publisher (2-5)Users License


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drug & Gene Delivery Devices Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rise in the prevalence rate of cardiovascular disorders (CVDs) and lifestyle disorders
5.1.1.2. Introduction of auto-injectors and advanced pulmonary devices
5.1.1.3. Rise in the consumption of drugs and therapeutic pharmaceuticals
5.1.2. Restraints
5.1.2.1. Increase in complications and expertise required in delivering therapeutics and drugs
5.1.3. Opportunities
5.1.3.1. Advancements in the field of drug and gene delivery systems such as smart nanoparticle technology, liposomes & hydrogels, and three-dimensional printing
5.1.3.2. Increasing ongoing research and development in the field of genomics for the development of gene delivery systems
5.1.4. Challenges
5.1.4.1. Increasing cost of high-end products
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Drug & Gene Delivery Devices Market, by Route of Administration
6.1. Introduction
6.2. Inhalation
6.3. Injectable
6.4. Nasal
6.5. Ocular
6.6. Oral
6.7. Topical
6.8. Transdermal
7. Drug & Gene Delivery Devices Market, by Method
7.1. Introduction
7.2. Ex vivo
7.3. In situ
8. Drug & Gene Delivery Devices Market, by Vector
8.1. Introduction
8.2. Non-viral
8.3. Viral
9. Americas Drug & Gene Delivery Devices Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Drug & Gene Delivery Devices Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Drug & Gene Delivery Devices Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 3M Company
13.1.2. Antares Pharma, Inc.
13.1.3. B. Braun SE
13.1.4. Baxter International Inc.
13.1.5. Becton, Dickinson and Company
13.1.6. Eisai Co., Ltd.
13.1.7. Enable Injections, Inc.
13.1.8. Gerresheimer AG
13.1.9. Insulet Corporation
13.1.10. Johnson & Johnson Services Inc.
13.1.11. Koninklijke Philips N.V.
13.1.12. Merck KGaA
13.1.13. OraSure Technologies, Inc.
13.1.14. Oxford BioMedica PLC
13.1.15. Sanofi S.A.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. DRUG & GENE DELIVERY DEVICES MARKET RESEARCH PROCESS
FIGURE 2. DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2023 VS 2030
FIGURE 3. DRUG & GENE DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DRUG & GENE DELIVERY DEVICES MARKET DYNAMICS
FIGURE 7. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
FIGURE 8. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2023 VS 2030 (%)
FIGURE 10. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2023 VS 2030 (%)
FIGURE 12. DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY VECTOR, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DRUG & GENE DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. DRUG & GENE DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. DRUG & GENE DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings